ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.430,58
0,71%
S&P 500
6.067,70
0,92%
Dow Jones
44.850,35
0,31%
Euro vs US Dollar
1,04335
0,05%
Bitcoin
101.466,81
0,13%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. RAPT Therapeutics Inc (RAPT)

  7. RAPT Therapeutics Inc (RAPT) News

RAPT

RAPT Therapeutics (RAPT)

RAPT Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:RAPT
DatumZeitQuelleÜberschriftSymbolFirma
28/01/202513h35Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:RAPTRAPT Therapeutics Inc
28/01/202506h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RAPTRAPT Therapeutics Inc
21/01/202522h58Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:RAPTRAPT Therapeutics Inc
13/01/202522h17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RAPTRAPT Therapeutics Inc
09/01/202514h00GlobeNewswire Inc.RAPT Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:RAPTRAPT Therapeutics Inc
07/01/202500h38Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:RAPTRAPT Therapeutics Inc
06/01/202522h31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RAPTRAPT Therapeutics Inc
06/01/202515h22Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:RAPTRAPT Therapeutics Inc
06/01/202514h00GlobeNewswire Inc.RAPT Therapeutics Names Lori Lyons-Williams Chair of the Company’s Board of DirectorsNASDAQ:RAPTRAPT Therapeutics Inc
03/01/202520h08Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:RAPTRAPT Therapeutics Inc
30/12/202421h32Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:RAPTRAPT Therapeutics Inc
23/12/202422h55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RAPTRAPT Therapeutics Inc
23/12/202422h42Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:RAPTRAPT Therapeutics Inc
23/12/202413h16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RAPTRAPT Therapeutics Inc
23/12/202413h10GlobeNewswire Inc.RAPT Therapeutics Announces $150 Million Private PlacementNASDAQ:RAPTRAPT Therapeutics Inc
23/12/202413h00GlobeNewswire Inc.RAPT Therapeutics and Shanghai Jemincare Pharmaceutical Announce Exclusive License Agreement for Novel Long-Acting anti-IgE AntibodyNASDAQ:RAPTRAPT Therapeutics Inc
15/11/202423h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RAPTRAPT Therapeutics Inc
14/11/202415h39Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:RAPTRAPT Therapeutics Inc
12/11/202414h03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RAPTRAPT Therapeutics Inc
12/11/202414h00GlobeNewswire Inc.RAPT Therapeutics Reports Third Quarter 2024 Financial ResultsNASDAQ:RAPTRAPT Therapeutics Inc
11/11/202414h00GlobeNewswire Inc.Based on Recent FDA Feedback RAPT Therapeutics Stops Zelnecirnon Program Following Clinical Hold Due to Single SAE of Severe Liver InjuryNASDAQ:RAPTRAPT Therapeutics Inc
08/08/202414h10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RAPTRAPT Therapeutics Inc
08/08/202414h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RAPTRAPT Therapeutics Inc
08/08/202414h00GlobeNewswire Inc.RAPT Therapeutics Reports Second Quarter 2024 Financial ResultsNASDAQ:RAPTRAPT Therapeutics Inc
19/07/202423h24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RAPTRAPT Therapeutics Inc
24/05/202400h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RAPTRAPT Therapeutics Inc
24/05/202400h16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RAPTRAPT Therapeutics Inc
24/05/202400h14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RAPTRAPT Therapeutics Inc
24/05/202400h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RAPTRAPT Therapeutics Inc
23/05/202422h49Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RAPTRAPT Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:RAPT

Kürzlich von Ihnen besucht

AQSE
HILS.GB
Hill & Smith
BOV
HALI34Q
Halliburton
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten